BLUE vs. IBRX
Compare and contrast key facts about bluebird bio, Inc. (BLUE) and ImmunityBio, Inc. (IBRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BLUE or IBRX.
Correlation
The correlation between BLUE and IBRX is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BLUE vs. IBRX - Performance Comparison
Key characteristics
BLUE:
-0.45
IBRX:
-0.37
BLUE:
-0.24
IBRX:
0.14
BLUE:
0.97
IBRX:
1.02
BLUE:
-0.68
IBRX:
-0.45
BLUE:
-1.32
IBRX:
-1.08
BLUE:
51.40%
IBRX:
39.19%
BLUE:
150.69%
IBRX:
114.60%
BLUE:
-99.80%
IBRX:
-97.14%
BLUE:
-99.72%
IBRX:
-93.80%
Fundamentals
BLUE:
$87.21M
IBRX:
$2.07B
BLUE:
-$36.00
IBRX:
-$0.90
BLUE:
$53.12M
IBRX:
$7.33M
BLUE:
-$23.10M
IBRX:
-$1.94M
BLUE:
-$99.14M
IBRX:
-$421.08M
Returns By Period
In the year-to-date period, BLUE achieves a -69.20% return, which is significantly lower than IBRX's -47.81% return.
BLUE
-69.20%
40.26%
-52.73%
-68.98%
-62.70%
-38.62%
IBRX
-47.81%
-46.26%
-63.91%
-35.78%
-4.46%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BLUE vs. IBRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for bluebird bio, Inc. (BLUE) and ImmunityBio, Inc. (IBRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BLUE vs. IBRX - Dividend Comparison
Neither BLUE nor IBRX has paid dividends to shareholders.
Drawdowns
BLUE vs. IBRX - Drawdown Comparison
The maximum BLUE drawdown since its inception was -99.80%, roughly equal to the maximum IBRX drawdown of -97.14%. Use the drawdown chart below to compare losses from any high point for BLUE and IBRX. For additional features, visit the drawdowns tool.
Volatility
BLUE vs. IBRX - Volatility Comparison
bluebird bio, Inc. (BLUE) has a higher volatility of 99.98% compared to ImmunityBio, Inc. (IBRX) at 42.53%. This indicates that BLUE's price experiences larger fluctuations and is considered to be riskier than IBRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BLUE vs. IBRX - Financials Comparison
This section allows you to compare key financial metrics between bluebird bio, Inc. and ImmunityBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities